A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer
Clinical trial NCT02567331 · COMPLETED
Trial details
- NCT number
- NCT02567331
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2006-04-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.